ReddRadar
What is Immunai?
Immunai is a biotechnology company focused on decoding the complexities of the immune system. The company leverages advanced technologies to map the immune system at an unprecedented scale and resolution, aiming to improve the development of immune-related therapeutics.
Immunai's platform supports critical decision-making throughout the drug discovery and development process. By integrating multiomic data generation, a vast immune-focused database (AMICA), and machine learning, Immunai provides actionable recommendations to accelerate the delivery of better therapies to patients.
Features
- Target Discovery: Identify novel high impact targets linked to disease
- Preclinical Evaluation: Prioritize the most promising drug candidates for development
- Clinical Trial Optimization: Better understand drug mechanism of action, identify the right groups of patients and the best treatment strategies to maximize trial success
- AMICA: The world’s largest immune-focused, harmonized single-cell database
- Multiomic Data Generation: High-quality multiomic data from clinical and preclinical samples
- Machine Learning Platform: Computes novel immune features, linking immune mechanisms to treatment responses and outcomes
- Functional Genomics Validation: Validates ML-driven hypotheses in the lab
Use Cases
- Identifying new therapeutic targets
- Prioritizing drug candidates
- Optimizing clinical trial design
- Understanding drug mechanisms of action
- Identifying patient populations for treatment
Related Queries
Helpful for people in the following professions
Featured Tools
Join Our Newsletter
Stay updated with the latest AI tools, news, and offers by subscribing to our weekly newsletter.
